Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Depreciation and Depletion (2018 - 2023)

Viemed Healthcare (VMD) has disclosed Depreciation and Depletion for 4 consecutive years, with $6.0 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Depreciation and Depletion rose 44.99% year-over-year to $6.0 million, compared with a TTM value of $20.3 million through Sep 2023, up 41.31%, and an annual FY2022 reading of $15.6 million, up 38.17% over the prior year.
  • Depreciation and Depletion was $6.0 million for Q3 2023 at Viemed Healthcare, up from $5.2 million in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $6.0 million in Q3 2023 and bottomed at $2.1 million in Q1 2020.
  • Average Depreciation and Depletion over 4 years is $3.5 million, with a median of $3.1 million recorded in 2021.
  • The sharpest move saw Depreciation and Depletion grew 9.98% in 2021, then surged 44.99% in 2023.
  • Year by year, Depreciation and Depletion stood at $2.8 million in 2020, then increased by 9.98% to $3.1 million in 2021, then soared by 40.16% to $4.4 million in 2022, then soared by 36.63% to $6.0 million in 2023.
  • Business Quant data shows Depreciation and Depletion for VMD at $6.0 million in Q3 2023, $5.2 million in Q2 2023, and $4.8 million in Q1 2023.